Latest Articles

The impetus to demonstrate regulatory compliance to ensure their products are safe for human consumption is an imperative for pharmaceutical and biotechnology organizations.

Thanks to the rise of AI, HTS for drug discovery is taking a more intelligent, computational approach, with tools that allow scientists to pinpoint the most promising drug candidates faster. Explore how this evolution will be further enhanced by a shift from 2D to 3D biological models such as organoids.

An organ-on-a-chip is a model system containing engineered cells grown inside microfluidic chips. This article will highlight some recent advances in organ-on-a-chip technology and how they are being used to improve disease modeling and drug discovery.

Due to the horsemeat scandal that rocked the European food industry in 2013, the industry as a whole is now more prepared to tackle incidents of suspected fraud. This article explores the analytical tools used to authenticate meat and tackle meat fraud.

It can be challenging for mothers to consume the necessary vitamins and minerals needed throughout pregnancy – including vitamin D, folate, calcium, iron and omega-3 fatty acids – from food alone, and oftentimes supplementation is required.

Using data provided by Intercontinental Exchange, My Green Lab has produced a report providing key insights into the current state of the sector’s carbon emissions. James Connelly highlights some of the key findings and their significance.

By replicating the microenvironment of human organs within microscale devices, OOAC technology has emerged as a powerful tool for understanding human physiology and disease mechanisms with unparalleled precision.

Neurodegenerative diseases are characterized by synapse dysfunction and the aggregation of proteins in the brain, which ultimately lead to neuronal loss. This article will review the studies and methods powering our growing understanding of the mechanisms behind neurodegenerative disease.

This article explores how biopharmaceutical organizations seeking to remain competitive must adopt innovations, like cell-free long DNA synthesis, to unleash the potential of synthetic biology and accelerate therapeutic development across all facets of genetic medicine.

The term cell therapy refers to the transfer of cellular materials into a patient for therapeutic purposes. Here, we look to introduce the different types of cell therapies, including stem-cell and non-stem cell-based unicellular therapies as well as multicellular therapies.